AmerisourceBergen snags sterile drug compounder PharMEDium in $2.5B deal

AmerisourceBergen ($ABC) is set to do its second $2.5 billion deal this year, again taking a turn into a new arena. The drug sourcing and distribution giant says it has a deal to buy PharMEDium, a sterile drug compounding specialist with a client list of more than 3,000 acute care hospitals for which it produces specialized products from four centers. In the spring, Valley Forge, PA-based AmerisourceBergen completed a $2.5 billion deal to buy international animal health distribution company MWI Veterinary Supply. Story | More

Suggested Articles

Only months removed from a gamechanging label expansion for Vascepa, Amarin is scrambling after a district judge invalidated the drug's key patents.

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.